By Brendan Pierson (Reuters) – Swiss drugmaker Novartis AG has agreed to pay $30 million to settle claims by health plans and consumers that it schemed to delay the U.S. …
Topic:
novartis
-
-
ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year. Ghostine has been …
-
(Reuters) -Swiss drugmaker Novartis AG is considering to sell its ophthalmology and respiratory units, a Bloomberg report said on Wednesday citing people familiar with the matter. The company is seeking …
-
DUBLIN (Reuters) – Novartis said on Thursday that it would cut up to 400 jobs in Ireland, or about a quarter of its workforce there, as part of a previously …
-
ZURICH (Reuters) – Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on Friday, citing inability to use …
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG – NVS
by Your NewsNEW YORK, July 13, 2022 — Pomerantz LLP is investigating claims on behalf of investors of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS). Such investors are advised to contact Robert S. Willoughby …
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Novartis AG – NVS
by Your NewsNEW YORK, July 5, 2022 — Pomerantz LLP is investigating claims on behalf of investors of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS). Such investors are advised to contact Robert S. Willoughby …
-
FRANKFURT – A targeted oral drug combination by Novartis won U.S. approval for use in a wide range of advanced solid tumours that are driven by a certain genetic contributor, …
-
FRANKFURT – An oral drug combination by Swiss pharmaceuticals company Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial. In …
-
ZURICH – Swiss drugmaker Novartis will cut thousands of jobs worldwide as it combines its pharma and oncology businesses in a reorganisation announced last week, Swiss newspaper Tages-Anzeiger reported on …
-
GENEVA – Swiss drugmaker Novartis said on Tuesday it was suspending capital investments, media advertising, and other promotional activities in Russia but remained committed to providing access to its medicine …
-
– Private equity firms Blackstone Inc and Carlyle Group Inc are in talks about potentially teaming up on a bid for Swiss drugmaker Novartis’ generics unit, Bloomberg News reported on …